In two studies, experiences with GLP‐1 RAs were as part of a clinical trial and here specific GLP‐1 RAs were reported, one using liraglutide for weight loss patients with severe mental illness [21], and one tirzepatide for T2DM [16]. Here, GLP1R is linked to psychiatric disorder.